Department of Neurology, University of Illinois at Chicago College of Medicine, 912 S Wood Street, Suite 164C, Chicago, IL, USA.
Neuropsychiatric Institute, NPI Building, M/C 796, Chicago, IL, 60612-7330, USA.
Curr Neurol Neurosci Rep. 2019 Feb 28;19(4):17. doi: 10.1007/s11910-019-0932-0.
Sickle cell anemia is a multiorgan disease with acute and chronic complications. Involvement of the central nervous system (CNS) is associated with increased mortality and morbidity. This review highlights the broad spectrum of neurological complications seen in patients with sickle cell disease.
Increasing recognition of neurological complications has led to improved diagnostic and treatment options throughout the years. Neurologic complications in sickle cell disease include silent cerebral ischemia, ischemic/hemorrhagic stroke, moyamoya syndrome, posterior reversible encephalopathy syndrome, cerebral fat embolism, and cerebral venous sinus thrombosis. Treatment varies depending on the neurological complication. Sickle cell disease is the most common hereditary anemia with increasing global disease burden. Early recognition and treatment is imperative.
镰状细胞贫血是一种多器官疾病,具有急性和慢性并发症。中枢神经系统(CNS)受累与死亡率和发病率增加相关。本篇综述强调了镰状细胞病患者中出现的广泛神经系统并发症。
近年来,对神经系统并发症的认识不断提高,导致诊断和治疗选择的改善。镰状细胞病中的神经并发症包括无症状性脑缺血、缺血/出血性中风、烟雾病、可逆性后部脑病综合征、脑脂肪栓塞和脑静脉窦血栓形成。治疗取决于神经系统并发症。镰状细胞病是最常见的遗传性贫血,全球疾病负担不断增加。早期识别和治疗至关重要。